| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4001182 | Urologic Oncology: Seminars and Original Investigations | 2006 | 4 Pages |
Abstract
We report on a 38-year-old male diagnosed with biopsy-proven bladder urothelial carcinoma metastatic to the bone, who had a complete response to neoadjuvant chemotherapy consisting of carboplatin and gemcitabine. The final pathology of his radical cystoprostatectomy revealed no residual cancer. The patient continues to be without evidence of disease 2 years postoperatively. This case shows that neoadjuvant chemotherapy with nonstandard regimens can yield responses in patients with bone metastases.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Fadi N. Joudi, Laila Dahmoush, David M. Spector, Badrinath R. Konety,